Presatovir (GS-5806) is an orally administered small molecule fusion inhibitor targeting respiratory syncytial virus (RSV), demonstrating potent antiviral activity with a mean EC50 of 0.43 nM. It has been utilized in both in vitro virology studies and in vivo preclinical models to investigate RSV infection and therapeutic intervention.
Molekulargewicht:
532.06
Reinheit:
99.92% (May vary between batches)
CAS Nummer:
[1353625-73-6]
Formel:
C24H30ClN7O3S
Target-Kategorie:
RSV
Anwendungsbeschreibung:
Solubility: DMSO:1 mg/mL (1.88 mM),H2O:Insoluble
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten